Ottenhofen, Germany

Tanja Bauer

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt. Active years: 2021.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tanja Bauer - Innovator in Hepatitis B Virus Treatment

Introduction

Tanja Bauer is a notable inventor based in Ottenhofen, Germany. She has made significant contributions to the field of medical research, particularly in the development of innovative treatments for viral infections.

Latest Patents

Tanja Bauer holds a patent for "Means and methods for treating HBV." This invention relates to an improved recombinant vaccination vector designed for the treatment or vaccination against the hepatitis B virus (HBV). The patent also encompasses pharmaceutical compositions or vaccines that include this recombinant vaccination vector. Furthermore, it details a recombinant vaccination vector intended for use in vaccination methods against HBV, along with kits that comprise a vaccine containing the recombinant vaccination vector.

Career Highlights

Throughout her career, Tanja Bauer has worked with prestigious research institutions, including the Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt. Her work has focused on advancing the understanding and treatment of viral infections, contributing to the development of effective vaccination strategies.

Collaborations

Tanja has collaborated with esteemed colleagues such as Ulrike Protzer and Anna Kosinska, enhancing her research through shared expertise and innovative ideas.

Conclusion

Tanja Bauer's work in developing a recombinant vaccination vector for hepatitis B virus treatment showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against viral infections, and her innovative spirit continues to inspire future research in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…